CH518951A - Verfahren zur Herstellung von 2-Amino-adenosinderivaten - Google Patents

Verfahren zur Herstellung von 2-Amino-adenosinderivaten

Info

Publication number
CH518951A
CH518951A CH1269468A CH1269468A CH518951A CH 518951 A CH518951 A CH 518951A CH 1269468 A CH1269468 A CH 1269468A CH 1269468 A CH1269468 A CH 1269468A CH 518951 A CH518951 A CH 518951A
Authority
CH
Switzerland
Prior art keywords
amino
preparation
adenosine derivatives
adenosine
derivatives
Prior art date
Application number
CH1269468A
Other languages
German (de)
English (en)
Inventor
Nat Koch Klaus Dr Rer
Erich Dr Techn Fauland
Stach Kurt Ing Dr
Nat Thiel Max Dr Rer
Wolfgang Prof Dr Med Schaumann
Karl Dr Med Dietmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Priority to CH1300470A priority Critical patent/CH511240A/de
Priority to CH1300370A priority patent/CH510676A/de
Publication of CH518951A publication Critical patent/CH518951A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1269468A 1967-08-25 1968-08-22 Verfahren zur Herstellung von 2-Amino-adenosinderivaten CH518951A (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CH1300470A CH511240A (de) 1967-08-25 1968-08-22 Verfahren zur Herstellung von 2-Amino-adenosinderivaten
CH1300370A CH510676A (de) 1967-08-25 1968-08-22 Verfahren zur Herstellung von 2-Amino-adenosinderivaten

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0094161 1967-08-25

Publications (1)

Publication Number Publication Date
CH518951A true CH518951A (de) 1972-02-15

Family

ID=6987386

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1269468A CH518951A (de) 1967-08-25 1968-08-22 Verfahren zur Herstellung von 2-Amino-adenosinderivaten

Country Status (11)

Country Link
US (1) US3590029A (fr)
JP (1) JPS4838719B1 (fr)
AT (3) AT282835B (fr)
CH (1) CH518951A (fr)
DE (1) DE1670265A1 (fr)
FI (1) FI50337C (fr)
FR (1) FR1587681A (fr)
GB (1) GB1164580A (fr)
IE (1) IE32299B1 (fr)
NL (1) NL6812083A (fr)
SE (1) SE349581B (fr)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038479A (en) * 1969-11-17 1977-07-26 Burroughs Wellcome Co. Amino purine derivatives
US3887706A (en) * 1969-12-12 1975-06-03 Schering Ag N6-(3-Chlorobuten-2-yl)-adenosines as anti-inflammatory agents
DE2059922A1 (de) * 1970-12-05 1972-06-15 Boehringer Mannheim Gmbh Neue N(6)-Aralkyl-adenosin-Derivate und Verfahren zur Herstellung derselben
US4027026A (en) * 1971-03-09 1977-05-31 Smith Kline & French Laboratories Limited Pharmaceutical compositions and methods of inhibiting H-2 histamine receptors with pyridyl substituted thioalkyl- and oxyalkyl-thioureas and ureas
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
BE789773A (fr) * 1971-10-08 1973-04-06 Schering Ag Adenosines n6 -substituees et leur procede de
US4090021A (en) * 1971-10-08 1978-05-16 Schering Aktiengesellschaft Process for the production of N6 -substituted adenosine nucleotides and products resulting therefrom
DE2157036A1 (de) * 1971-11-17 1973-05-24 Boehringer Mannheim Gmbh Neue heterocyclisch substituierte nebularin-derivate und verfahren zu deren herstellung
DE2244328A1 (de) * 1972-09-09 1974-03-21 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2359536C2 (de) * 1972-12-08 1984-08-02 Takeda Chemical Industries, Ltd., Osaka 2,6-Diaminonebularinderivate
DE2338963A1 (de) * 1973-08-01 1975-02-13 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
US4016262A (en) * 1973-08-01 1977-04-05 Boehringer Mannheim G.M.B.H. Therapeutic compositions and methods employing N(6)-disubstituted adenosine compounds
US3992531A (en) * 1973-12-26 1976-11-16 Abbott Laboratories 2-Substituted adenosine-5'-carboxylates in the treatment of anginal pain
US4171432A (en) * 1978-06-22 1979-10-16 Miles Laboratories, Inc. Flavin adenine dinucleotide-iodothyronine conjugates
JPS57171998A (en) * 1981-04-15 1982-10-22 Fujisawa Pharmaceut Co Ltd Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same
CA1239397A (fr) * 1983-08-01 1988-07-19 James A. Bristol Adenosines substituee en position n.sup.6
US4501735A (en) * 1983-12-05 1985-02-26 Warner-Lambert Company N6-(1- and 2-benzocycloalkyl) adenosines
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
EP0305643B1 (fr) * 1984-04-18 1994-01-05 Whitby Research Incorporated Dérivés d'adénosine N-6-thiényl substituée comme vasodilatateurs cardiaques
US5310731A (en) * 1984-06-28 1994-05-10 Whitby Research, Inc. N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
CA1254888A (fr) * 1984-10-26 1989-05-30 Bharat Trivedi N.sup.6-bicyclo-adenosines
US4614732A (en) * 1984-10-26 1986-09-30 Warner-Lambert Company N6 -acenaphthyl adenosines and analogs thereof
US4593019A (en) * 1984-10-26 1986-06-03 Warner-Lambert Company N6 -tricyclic adenosines
AU579412B2 (en) * 1984-10-26 1988-11-24 Warner-Lambert Company N` - substituted adenosines
US4673670A (en) * 1985-09-05 1987-06-16 Warner-Lambert Company N6 -acenaphthyl adenosines and analogs thereof
US4954504A (en) * 1986-11-14 1990-09-04 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity
US5063233A (en) * 1986-11-14 1991-11-05 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists
US4843066A (en) * 1986-11-27 1989-06-27 Nippon Zoki Pharmaceutical Co., Ltd. Novel adenosine derivatives and pharmaceutical composition containing them as an active ingredient
US4968697A (en) * 1987-02-04 1990-11-06 Ciba-Geigy Corporation 2-substituted adenosine 5'-carboxamides as antihypertensive agents
US5034381A (en) * 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
US5032584A (en) * 1988-10-26 1991-07-16 G. D. Searle & Co. S-diastereomer of an n6 -((2-hydroxypropyl)aryl)adenosine and its medicinal uses
US5030624A (en) * 1988-10-26 1991-07-09 G. D. Searle & Co. R-diastereomer of an N6 -[(2-hydroxypropyl)aryl]adenosine and its medicinal uses
US4992535A (en) * 1988-10-26 1991-02-12 G. D. Searle & Co. Methods of making novel R and S diastereomers of N6 -[(2-hydroxypropyl)aryl]adenosines
US5391739A (en) * 1989-03-29 1995-02-21 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5256650A (en) * 1989-03-29 1993-10-26 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
DK62592D0 (fr) * 1992-05-14 1992-05-14 Novo Nordisk As
US5672588A (en) * 1992-05-20 1997-09-30 Novo Nordisk A/S Purine derivatives
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5683989A (en) * 1993-12-17 1997-11-04 Novo Nordisk A/S Treatment of ischemias by administration of 2,N6 -substituted adenosines
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
EP0799040B1 (fr) * 1994-12-13 2003-08-20 Euroceltique S.A. Thioxanthines trisubstituees
ATE247116T1 (de) * 1994-12-13 2003-08-15 Euro Celtique Sa Arylthioxanthine
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
US6784165B1 (en) 1999-11-23 2004-08-31 Aderis Pharmaceuticals, Inc. Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
DE60118521T2 (de) * 2000-01-07 2006-10-12 Universitaire Instelling Antwerpen Purin derivate, ihre herstellung und verwendung
CZ294538B6 (cs) * 2002-12-30 2005-01-12 Ústav Experimentální Botaniky Akademie Vědčeské Re Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
WO2004100964A1 (fr) * 2003-04-24 2004-11-25 Aderis Pharmaceuticals, Inc. Methode de traitement de la fibrillation auriculaire ou du flutter auriculaire
US20050118262A1 (en) * 2003-09-17 2005-06-02 Jack Aurora Controlled release formulation
CZ2009298A3 (cs) * 2009-05-14 2010-11-24 Univerzita Palackého v Olomouci Substituované 6-benzylaminopurin ribosidy, jejich použití a farmaceutický prípravek tyto slouceniny obsahující
US20120295863A1 (en) * 2009-11-13 2012-11-22 Yun-Lian Lin Dual-Action Compounds Targeting Adenosine A2A Receptor and Adenosine Transporter for Prevention and Treatment of Neurodegenerative Diseases

Also Published As

Publication number Publication date
GB1164580A (en) 1969-09-17
FR1587681A (fr) 1970-03-27
AT282835B (de) 1970-07-10
JPS4838719B1 (fr) 1973-11-19
SE349581B (fr) 1972-10-02
IE32299L (en) 1969-02-25
FI50337C (fi) 1976-02-10
IE32299B1 (en) 1973-06-13
FI50337B (fr) 1975-10-31
AT292202B (de) 1971-08-25
AT292203B (de) 1971-08-25
US3590029A (en) 1971-06-29
NL6812083A (fr) 1969-02-27
DE1670265A1 (de) 1971-01-28

Similar Documents

Publication Publication Date Title
CH518951A (de) Verfahren zur Herstellung von 2-Amino-adenosinderivaten
CH511233A (de) Verfahren zur Herstellung von Isochinuklidin-Derivaten
AT281778B (de) Verfahren zur Herstellung von Alk-3-en-1-olen
AT283594B (de) Verfahren zur Herstellung von 7-Halogen-octopyranosiden
CH541580A (de) Verfahren zur Herstellung von Bis-thioureidobenzol-derivaten
AT279602B (de) Verfahren zur Herstellung von Pyrrol-3-yl-ketonen
CH499541A (de) Verfahren zur Herstellung von Pyridyl-benzopyranen
CH529145A (de) Verfahren zur Herstellung von 1-Aminoalkylbenzodiazepinderivaten
CH502292A (de) Verfahren zur Herstellung von o-Isopropylaminobenzophenonen
AT283357B (de) Verfahren zur Herstellung von 2-Aryl-v-triazolen
CH483425A (de) Verfahren zur Herstellung von p-Alkoxy-piperidin-amiden
AT273953B (de) Verfahren zur Herstellung von v-Triazolyl-cumarinderivaten
CH516536A (de) Verfahren zur Herstellung von Benzolsulfonylsemicarbaziden
AT278001B (de) Verfahren zur Herstellung von N-Trityl-imidazolen
CH484930A (de) Verfahren zur Herstellung von Aryloxazolen
AT281420B (de) Verfahren zur Herstellung von α-Triorganosiloxy-ω-hydroxy-diorganopolysiloxanen
CH497438A (de) Verfahren zur Herstellung von Difluor-s-triazinen
CH507233A (de) Verfahren zur Herstellung von Kalamycinderivaten
AT280309B (de) Verfahren zur Herstellung von 3-Methansulfonylphenthiazinen
CH498114A (de) Verfahren zur Herstellung von 2-N-substituierten 2-Amino-5-nitropyridinen
AT284140B (de) Verfahren zur Herstellung von Pyrazinamidoguanidinen
CH483396A (de) Verfahren zur Herstellung von 1-Brom-4-acylamino-anthrachinonen
CH496000A (de) Verfahren zur Herstellung von Benzimidazol-N-Oxyden
CH499492A (de) Verfahren zur Herstellung von äthinylsubstituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
CH529146A (de) Verfahren zur Herstellung von 1-Alkyl-nitrobenzodiazepinderivaten

Legal Events

Date Code Title Description
PL Patent ceased